There has been much concern and discussion about Commerce Secretary Howard Lutnick\u2019s recent letter to Harvard University indicating the U.S. government\u2019s exercise of its \u201cmarch-in rights\u201d for government-funded research resulting in IP owned by Harvard under the Bayh-Dole Act. Under the Bayh-Dole Act, recipients of U.S. government research contracts can own any IP resulting from that research, but there are some out-licensing restrictions on that IP, including a requirement to achieve practical application of the subject invention, domestic manufacture, small-entity out-license preference and reporting of all commercialization activities, including the filing of patent applications.<\/p>\n\n\n\n
Note<\/em>: Co-author Ryan Smith previously worked in the technology transfer office of a major California university managing iEdison reporting of commercialization efforts to comply with the requirements of the Bayh-Dole Act.<\/p>\n\n\n\n Read the full story on the Duane Morris LLP website<\/a>.<\/p>\n\n\n\n <\/p>\n","protected":false},"excerpt":{"rendered":" There has been much concern and discussion about Commerce Secretary Howard Lutnick\u2019s recent letter to Harvard University indicating the U.S. government\u2019s exercise of its \u201cmarch-in rights\u201d for government-funded research resulting in IP owned by Harvard under the Bayh-Dole Act. Under the Bayh-Dole Act, recipients of U.S. government research contracts can own any IP resulting from … <\/p>\n Continue reading “Commerce Department Singles Out Harvard for Bayh-Dole March-In Rights Enforcement”<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"ppma_author":[521,517,522],"class_list":["post-499","post","type-post","status-publish","format-standard","hentry","category-general"],"authors":[{"term_id":521,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/843ff6e7a8fe5fc92109b47a45f34b6cf0ea499e6e788db23456c838b0ae6747?s=96&d=blank&r=g","author_category":"1","last_name":"Sullivan","first_name":"Margaret","job_title":"","user_url":"http:\/\/www.duanemorris.com","description":"Visit the Duane Morris website.<\/a>"},{"term_id":517,"user_id":22,"is_guest":0,"slug":"vgnorton","display_name":"Vicki G. Norton, Ph.D.","avatar_url":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-content\/uploads\/sites\/15\/2014\/08\/nortonvicki-125x150.jpg","author_category":"","last_name":"Norton, Ph.D.","first_name":"Vicki G.","job_title":"","user_url":"http:\/\/www.duanemorris.com\/attorneys\/vickignorton.html","description":"Read Vicki's bio.<\/a>"},{"term_id":522,"user_id":233,"is_guest":0,"slug":"rcsmith","display_name":"Ryan Smith, Ph.D.","avatar_url":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-content\/uploads\/sites\/15\/2015\/04\/smithryan-125x150.jpg","author_category":"","last_name":"Smith","first_name":"Ryan","job_title":"","user_url":"http:\/\/www.duanemorris.com\/attorneys\/ryancsmith.html","description":"Read Ryan's bio.<\/a>"}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/comments?post=499"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/499\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/media?parent=499"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/categories?post=499"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/tags?post=499"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/ppma_author?post=499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}